You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百濟神州(688235.SH):百澤安®三項新增適應症、百悦澤®一項新增適應症和百匯澤®新藥納入國家醫保目錄(2021年)
格隆匯 01-10 17:02

格隆匯1月10日丨百濟神州(688235.SH)公佈,根據國家醫療保障局、人力資源社會保障部發布的《國家基本醫療保險、工傷保險和生育保險藥品目錄(2021年)》(醫保發〔2021〕50號),百濟神州有限公司產品抗PD-1抗體藥物百澤安®(替雷利珠單抗注射液)三項新增適應症、BTK抑制劑百悦澤®(澤布替尼膠囊)一項新增適應症和PARP抑制劑百匯澤®(帕米帕利膠囊)新藥納入國家醫保目錄(2021年)。

本次公司三款產品納入國家醫保目錄(2021年),體現了國家醫療保障局對臨牀價值高、價格合理的創新藥品的支持和認可。納入國家醫保目錄(2021年)將有助於公司進一步提高該等產品在患者中的可負擔性和可及性,也將有利於該等產品的市場推廣和銷售,對公司的長期經營發展具有一定積極作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account